Ingredient

Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt

⚠ EU Restricted

Identification

CAS Number 5863-51-4
EINECS / EC 227-513-4
CosIng Ref 30461
Chemical Name sodium 3-[[4-[(E)-(2-chlorophenyl)-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate
IUPAC Name —
Formula C39H38ClN2NaO6S2
Mol. Weight 753.3 g/mol
InChIKey AYQGOOLZDOHXAY-UHFFFAOYSA-M

Function & Classification

EU Regulatory Status

🇪🇺
⚠ Restricted — EU Reg. 1223/2009 IV

Safety Profile

No toxicology data available yet for this ingredient.

Check SCCS opinions or CIR reports for published safety assessments.

NOAEL · Dermal Absorption % · Sensitization

Formulation Guidelines

Usage level, pH range, solubility and addition phase not yet available.

Usage Level % · Addition Phase · Solubility

Suppliers & Documents

Log in to see suppliers.

Log in or register to see suppliers and documents for Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt.

Documents

External Resources